Annual Total Long Term Liabilities
$22.11 M
+$10.07 M+83.65%
31 December 2023
Summary:
Vaxcyte annual total long term liabilities is currently $22.11 million, with the most recent change of +$10.07 million (+83.65%) on 31 December 2023. During the last 3 years, it has risen by +$21.99 million (+18023.77%). PCVX annual total long term liabilities is now -86.27% below its all-time high of $161.02 million, reached on 31 December 2019.PCVX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$18.32 M
+$34.00 K+0.19%
30 September 2024
Summary:
Vaxcyte quarterly total long term liabilities is currently $18.32 million, with the most recent change of +$34.00 thousand (+0.19%) on 30 September 2024. Over the past year, it has increased by +$10.54 million (+135.41%). PCVX quarterly long term liabilities is now -88.62% below its all-time high of $161.02 million, reached on 31 December 2019.PCVX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +83.7% | +135.4% |
| 3 y3 years | +10000.0% | +2714.4% |
| 5 y5 years | -81.8% | - |
PCVX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -17.1% | +2714.4% |
| 5 y | 5 years | -86.3% | >+9999.0% | -88.6% | >+9999.0% |
| alltime | all time | -86.3% | >+9999.0% | -88.6% | >+9999.0% |
Vaxcyte Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.32 M(+0.2%) |
| June 2024 | - | $18.29 M(-9.5%) |
| Mar 2024 | - | $20.22 M(-8.6%) |
| Dec 2023 | $22.11 M(+83.6%) | $22.11 M(+184.1%) |
| Sept 2023 | - | $7.78 M(-15.6%) |
| June 2023 | - | $9.23 M(-13.3%) |
| Mar 2023 | - | $10.64 M(-11.6%) |
| Dec 2022 | $12.04 M | $12.04 M(-10.4%) |
| Sept 2022 | - | $13.45 M(-8.2%) |
| June 2022 | - | $14.65 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $15.93 M(+37.2%) |
| Dec 2021 | $11.60 M(+9410.7%) | $11.60 M(+1682.3%) |
| Sept 2021 | - | $651.00 K(+100.3%) |
| June 2021 | - | $325.00 K(-18.3%) |
| Mar 2021 | - | $398.00 K(+226.2%) |
| Dec 2020 | $122.00 K(-99.9%) | $122.00 K(-5.4%) |
| Sept 2020 | - | $129.00 K(-10.4%) |
| June 2020 | - | $144.00 K(-11.7%) |
| Mar 2020 | - | $163.00 K(-99.9%) |
| Dec 2019 | $161.02 M(+32.2%) | $161.02 M |
| Dec 2018 | $121.82 M | - |
FAQ
- What is Vaxcyte annual total long term liabilities?
- What is the all time high annual total long term liabilities for Vaxcyte?
- What is Vaxcyte annual total long term liabilities year-on-year change?
- What is Vaxcyte quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Vaxcyte?
- What is Vaxcyte quarterly long term liabilities year-on-year change?
What is Vaxcyte annual total long term liabilities?
The current annual total long term liabilities of PCVX is $22.11 M
What is the all time high annual total long term liabilities for Vaxcyte?
Vaxcyte all-time high annual total long term liabilities is $161.02 M
What is Vaxcyte annual total long term liabilities year-on-year change?
Over the past year, PCVX annual total long term liabilities has changed by +$10.07 M (+83.65%)
What is Vaxcyte quarterly total long term liabilities?
The current quarterly long term liabilities of PCVX is $18.32 M
What is the all time high quarterly long term liabilities for Vaxcyte?
Vaxcyte all-time high quarterly total long term liabilities is $161.02 M
What is Vaxcyte quarterly long term liabilities year-on-year change?
Over the past year, PCVX quarterly total long term liabilities has changed by +$10.54 M (+135.41%)